ADPribosylation and Ubiquitination; post-translational interplay

This project aims to investigate the interplay between ubiquitination and ADPribosylation in cellular processes to develop novel therapeutic strategies for diseases like infections and cancer.

Subsidie
€ 1.999.625
2024

Projectdetails

Introduction

Post-translational modification of proteins is essential in regulating proper cellular homeostasis. The attachment and removal of the small protein Ubiquitin (Ub) is, among others, involved in regulating immune response, cell cycle progression, and proteasome-mediated protein degradation.

Role of ADPr

The (de)conjugation of adenosine-di-phosphate ribose (ADPr) on the other hand is essential in regulating DNA damage responses and apoptosis. ADPribosylation and ubiquitination both dictate a highly complex signaling code. Intriguingly, these two PTM systems also communicate, as Ub was recently found to be ADPribosylated on multiple different positions.

Importance of Ubiquitination and ADPribosylation

This new layer of controlling ubiquitination plays important roles in intracellular bacterial replication, DNA damage repair, and tumor development. Understanding this fascinating post-translational interplay and the role the different UbADPr-isotypes play in cell biology is crucial to develop novel strategies for therapeutic intervention in diseases such as infectious diseases and cancers.

Research Questions

What are the mechanisms, biochemical scope of protein-protein interactions, cell biological consequences, and differences between these non-studied UbADPr linkages?

Proposed Study

I propose to study the entire system of dynamic ADPribosylation of Ub and explain the molecular details of the (de)conjugating enzymes. I will explore the cell biological networks involved and exploit the key enzymes for inhibitor discovery en route to future therapeutic intervention.

Methodology

  1. Develop novel chemical methodologies.
  2. Create a set of new substrates, activity-based probes, and assay reagents.
  3. Use these tools to:
    • Profile specificity and preferences of the involved enzymes.
    • Study the interactions and pathways in cells.
    • Screen for small molecule inhibitors.

Expertise and Goals

Using my expertise in protein synthesis and chemical- and structural biology, I aim to unveil the details of this until now poorly studied, but crucial, hidden layer of post-translational interplay in an unbiased manner.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.999.625
Totale projectbegroting€ 1.999.625

Tijdlijn

Startdatum1-1-2024
Einddatum31-12-2028
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • ACADEMISCH ZIEKENHUIS LEIDENpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC STG

Chemical rewiring of E3 ubiquitin ligases as a generalizable therapeutic approach

TrickE3 aims to systematically develop monovalent degraders to target undruggable proteins in pancreatic cancer, enhancing drug discovery and expanding the human proteome's targetable space.

€ 1.499.625
ERC POC

Development and commercialization of a kit for profiling enzyme activity in liquid biopsies

Developing a high-throughput PTM-profiling tool to monitor ubiquitination in clinical samples for discovering diagnostics and therapeutics in autoimmunity.

€ 150.000
ERC ADG

Ubiquitin-Proteasome System crosstalk with Metabolism

This project aims to elucidate the regulatory crosstalk between ubiquitination and cellular metabolites using advanced biophysical techniques to enhance understanding of metabolic homeostasis.

€ 2.089.688
ERC STG

Conjugation of NAD-capped RNAs to proteins by ADP-ribosyltransferases to generate RNA therapeutics

This project aims to develop RNAylated proteins as innovative RNA therapeutics by establishing design principles and delivery strategies to regulate cellular processes, including targeting the p53 protein.

€ 1.499.162